Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs

The data concerning antipsychotic-like activity of negative allosteric modulators (NAMs)/antagonists of mGlu7 receptors are limited. The only available ligands for this receptor are MMPIP and ADX71743. In the present studies, we used stable cell line expressing mGlu7 receptor and it was shown that b...

Full description

Bibliographic Details
Main Authors: Paulina Cieślik, Monika Woźniak, Katarzyna Kaczorowska, Piotr Brański, Grzegorz Burnat, Agnieszka Chocyk, Bartosz Bobula, Piotr Gruca, Ewa Litwa, Agnieszka Pałucha-Poniewiera, Agnieszka Wąsik, Andrzej Pilc, Joanna Wierońska
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2018.00316/full
id doaj-66f5e82cf27e42e083abcb496054ea7a
record_format Article
spelling doaj-66f5e82cf27e42e083abcb496054ea7a2020-11-24T22:09:56ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992018-09-011110.3389/fnmol.2018.00316407635Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic DrugsPaulina CieślikMonika WoźniakKatarzyna KaczorowskaPiotr BrańskiGrzegorz BurnatAgnieszka ChocykBartosz BobulaPiotr GrucaEwa LitwaAgnieszka Pałucha-PoniewieraAgnieszka WąsikAndrzej PilcJoanna WierońskaThe data concerning antipsychotic-like activity of negative allosteric modulators (NAMs)/antagonists of mGlu7 receptors are limited. The only available ligands for this receptor are MMPIP and ADX71743. In the present studies, we used stable cell line expressing mGlu7 receptor and it was shown that both compounds dose-dependently potentiated forskolin elevated cAMP concentration in the T-REx 293 cells, showing their inverse agonist properties. Subsequently, pharmacokinetic studies were performed. Both compounds were given intraperitoneally (i.p.) at the dose of 10 mg/kg and reached Cmax 0.25–0.5 h after administration, and then they declined rapidly, ADX71743 being almost undetectable 2 h after administration, while the concentration of MMPIP was still observed, suggesting that the concentration of MMPIP was more stable. Finally, we investigated the role of both mGlu7 receptor NAMs in animal models of schizophrenia. Behavioral tests commonly used in antipsychotic drug discovery were conducted. Both tested compounds dose-dependently inhibited MK-801-induced hyperactivity (MMPIP at 15 mg/kg; ADX at 5 and 15 mg/kg) and DOI-induced head twitches (MMPIP at 5, 10, 15 mg/kg; ADX at 2.5, 5, 10 mg/kg). Moreover, the same effects were noticed in novel object recognition test, where MMPIP (5, 10, 15 mg/kg) and ADX71743 (1, 5, 15 mg/kg) reversed MK-801-induced disturbances. In the social interaction test, antipsychotic activity was observed only for ADX71743 (5, 15 mg/kg). ADX71743 at the dose 2.5 mg/kg reversed MK-801-induced disruption in prepulse inhibition while MMPIP at 10 mg/kg reversed MK-801-induced disruption in spatial delayed alternation. The present studies showed that mGlu7 receptor may be considered as a putative target for antipsychotic drugs, though more studies are needed due to limited number of available ligands.https://www.frontiersin.org/article/10.3389/fnmol.2018.00316/fullschizophreniametabotropic glutamate receptor 7antipsychoticnegative allosteric modulatorsMMPIPADX71743
collection DOAJ
language English
format Article
sources DOAJ
author Paulina Cieślik
Monika Woźniak
Katarzyna Kaczorowska
Piotr Brański
Grzegorz Burnat
Agnieszka Chocyk
Bartosz Bobula
Piotr Gruca
Ewa Litwa
Agnieszka Pałucha-Poniewiera
Agnieszka Wąsik
Andrzej Pilc
Joanna Wierońska
spellingShingle Paulina Cieślik
Monika Woźniak
Katarzyna Kaczorowska
Piotr Brański
Grzegorz Burnat
Agnieszka Chocyk
Bartosz Bobula
Piotr Gruca
Ewa Litwa
Agnieszka Pałucha-Poniewiera
Agnieszka Wąsik
Andrzej Pilc
Joanna Wierońska
Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
Frontiers in Molecular Neuroscience
schizophrenia
metabotropic glutamate receptor 7
antipsychotic
negative allosteric modulators
MMPIP
ADX71743
author_facet Paulina Cieślik
Monika Woźniak
Katarzyna Kaczorowska
Piotr Brański
Grzegorz Burnat
Agnieszka Chocyk
Bartosz Bobula
Piotr Gruca
Ewa Litwa
Agnieszka Pałucha-Poniewiera
Agnieszka Wąsik
Andrzej Pilc
Joanna Wierońska
author_sort Paulina Cieślik
title Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
title_short Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
title_full Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
title_fullStr Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
title_full_unstemmed Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
title_sort negative allosteric modulators of mglu7 receptor as putative antipsychotic drugs
publisher Frontiers Media S.A.
series Frontiers in Molecular Neuroscience
issn 1662-5099
publishDate 2018-09-01
description The data concerning antipsychotic-like activity of negative allosteric modulators (NAMs)/antagonists of mGlu7 receptors are limited. The only available ligands for this receptor are MMPIP and ADX71743. In the present studies, we used stable cell line expressing mGlu7 receptor and it was shown that both compounds dose-dependently potentiated forskolin elevated cAMP concentration in the T-REx 293 cells, showing their inverse agonist properties. Subsequently, pharmacokinetic studies were performed. Both compounds were given intraperitoneally (i.p.) at the dose of 10 mg/kg and reached Cmax 0.25–0.5 h after administration, and then they declined rapidly, ADX71743 being almost undetectable 2 h after administration, while the concentration of MMPIP was still observed, suggesting that the concentration of MMPIP was more stable. Finally, we investigated the role of both mGlu7 receptor NAMs in animal models of schizophrenia. Behavioral tests commonly used in antipsychotic drug discovery were conducted. Both tested compounds dose-dependently inhibited MK-801-induced hyperactivity (MMPIP at 15 mg/kg; ADX at 5 and 15 mg/kg) and DOI-induced head twitches (MMPIP at 5, 10, 15 mg/kg; ADX at 2.5, 5, 10 mg/kg). Moreover, the same effects were noticed in novel object recognition test, where MMPIP (5, 10, 15 mg/kg) and ADX71743 (1, 5, 15 mg/kg) reversed MK-801-induced disturbances. In the social interaction test, antipsychotic activity was observed only for ADX71743 (5, 15 mg/kg). ADX71743 at the dose 2.5 mg/kg reversed MK-801-induced disruption in prepulse inhibition while MMPIP at 10 mg/kg reversed MK-801-induced disruption in spatial delayed alternation. The present studies showed that mGlu7 receptor may be considered as a putative target for antipsychotic drugs, though more studies are needed due to limited number of available ligands.
topic schizophrenia
metabotropic glutamate receptor 7
antipsychotic
negative allosteric modulators
MMPIP
ADX71743
url https://www.frontiersin.org/article/10.3389/fnmol.2018.00316/full
work_keys_str_mv AT paulinacieslik negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT monikawozniak negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT katarzynakaczorowska negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT piotrbranski negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT grzegorzburnat negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT agnieszkachocyk negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT bartoszbobula negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT piotrgruca negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT ewalitwa negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT agnieszkapałuchaponiewiera negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT agnieszkawasik negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT andrzejpilc negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
AT joannawieronska negativeallostericmodulatorsofmglu7receptorasputativeantipsychoticdrugs
_version_ 1725809961645113344